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Prostate cancer (PCa) is the second most common cancer in men in the US. Many Prostate 
cancers are Indolent and don’t result in cancer mortality, even without treatment. However, a significant 
proportion of patients with Prostate cancer have aggressive tumors that progress rapidly to metastatic 
disease and are often dangerous. Currently, treatment decisions for PCa patients are guided by various 
stratification algorithms. Among these parameters, the most important predictor of PCa mortality is the 
Gleason Grade (ranges from 6 to 10). Although current risk stratification tools are moderately effective, 
limitation remains in their ability to distinguish truly Indolent from aggressive and potentially lethal 
disease. Here we propose the use of Machine Learning (ML) for the classification of PC patients as having 
either indolent or aggressive using transcriptome data. We hypothesize that genomic alterations could 
lead to measurable changes distinguishing indolent from aggressive tumors. We also trained a Stacking-
based model with a different set of combinations of classifiers. The highest overall accuracy of our 
stacking model (all samples with Gleason Grade: 6, 7, 8, 9, and 10) is 95.758% and (samples with Gleason 
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Chapter 1 – Introduction 
 
Prostate cancer (PCa) is the most common solid tumor and the second most common 
cause of cancer death in the United States [1]. To date, treatment decisions for PCa patients are 
guided by various risk stratification algorithms [2]. These stratification algorithms are used for 
identifying and predicting the patients, who are at high risk or likely to be at high risk with the 
disease. Among the parameters used, the most potent predictor of PCa mortality is the Gleason 
grade (GG) [3, 4]. The GG ranges from 6 to 10. The majority of PCa present GG 6. These cancers 
are associated with very low cancer-specific mortality rates, even in the absence of therapy.  
Intermediated grade PCa presents GG 7. These cancers present a much more variable clinical 
course. Localized high grade (aggressive) with lethal potential PCa presents GG: 8 to 10. These 
tumors are aggressive, progress rapidly to metastatic disease, and are often lethal. Although 
current stratification protocols are moderately effective, significant challenges remain classifying 
PCas into Indolent and Aggressive. A key knowledge gap and critical unmet medical need are 
distinguishing patients with truly indolent tumors from those with aggressive tumors.  
PCa screening using the prostate-specific antigen (PSA) has led to the earlier detection of 
PCa with fewer men today presenting with metastatic disease[5]. However, although PSA has led 
to a reduction in mortality rate, it has also resulted in unintended consequences. The unintended 
consequences include over-diagnosis, which leads to overtreatment of patients indolent PCa, and 
under-treatment of patients with aggressive disease. Concerns about PSA-based screening led to 
the issuing of a D grade recommendation of its use by the US Preventive Services Task Force in 
2012 [6]. Crucially, a review for the U.S. Preventive Services Task Force concluded that PSA-based 
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screening results, either small or no reduction in prostate cancer-specific mortality [7]. It is 
associated with harms related to subsequent treatments and evaluation - some of them may be 
unnecessary. These concerns have heightened the need for the development of novel risk 
stratification algorithms to identify patients at high risk of developing aggressive tumors, which 
could be prioritized for treatment, and discovery of molecular markers separating the truly 
indolent disease from aggressive disease. 
Here we propose the use of machine learning (ML) for classification of PC patients into 
two groups, those with genuinely indolent tumors and those with aggressive tumors using 
transcriptome data. Statistics does simpler things, and when coming to a complex environment, 
it would be hard to predict. Implementing ML can help in predicting things more accurately and 
come up with better results. Our working hypothesis is that genomic alterations in patients 
diagnosed with indolent and aggressive could lead to measurable changes distinguishing the two 
patient groups, and that application of ML to genomics data would accurately distinguish the two 
patient groups. We addressed this hypothesis using transcriptome data on patients diagnosed 










Chapter 2 – Literature Review 
 
2.1 Background and Related Works 
Prostate cancer is characterized by malignant tumors found within the prostate gland in 
menage 65 and older. Currently, it is diagnosed with a blood test called Prostate Specific Antigen 
(PSA) test. Various attempts were made to classify cancer-based tissue samples using microarray, 
clinical, imaging, and RNA sequencing data. A new approach is developed to improve accuracy 
when using microarray data for classification [8]. Some of the recent studies attempted to 
diagnose prostate cancer with machine learning utilized microarray datasets.  Few of them 
conducted using various methods and were tested on different datasets [9-11]. They aim to 
predict if cancer is metastasizing or not, and the results of all microarray datasets are significant.  
The TCGA database is already used for classifying different types of cancers, and the data 
contained goes beyond RNA sequencing data in the TCGA database. Few published studies used 
breast cancer datasets for cancer classification [12, 13]. The challenges associated with datasets 
from the TCGA database are class imbalanced and are high dimensionality. If the dataset is high 
dimensional, the model cannot separate the classes accurately, and the result obtained will be 
very poor. Moreover, If the dataset is a class imbalance, the number of features will be much 
more than the number of samples, and the model becomes unstable and cause overfitting 
problem. Few studies faced the same problem using TCGA datasets [12, 13]. 
Lei Yang et al. [14] used Random walk with restart algorithm (RWRA) and Graph-regularized 
Nonnegative Matrix Factorization (GNMF) methods for molecular classification of prostate 
adenocarcinoma by the integrated somatic mutation profiles and molecular network. They 
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analyze somatic point mutations in exome sequences from TCGA-prostate samples and obtained 
with better results. 
 In one of the recent study [12], they used Stacked denoising Autoencoder (SDAE), PCA, KPCA, 
and differentially expressed gene methods to reduce the dimensionality. They also tried different 
methods like Artificial Neural network (ANN), Support-Vector Machine (SVM), Support-Vector 
Machine (SVM) with linear kernel, and Support-Vector Machine with Radial basis function kernel 
(SVM-RBF). The highest accuracy was obtained by SVM-RBF using the SDAE method for 
dimensionality reduction, and the highest sensitivity is achieved by the ANN model, followed by 
the SDAE method. The highest specificity and precision are obtained by the SVM-RBF model. 
Glocuk et al. [13] aimed to increase accuracy by performing different dimensionality methods 
like PCA, KPCA, and NMF. They tried implementing ladder network and found that it is 
outperforming SDAE and AVM models. 
Takumi et al. [15] tried machine learning to diagnose prostate cancer using clinical data. They 
implemented an Artificial Neural Network (ANN) with the data and found that although their 
model performed well, improvements need to be made before being suitable for clinical 
applications. 
A recent study [16] implemented the SMOTE technique to increase the number of samples in the 
data set to deal with imbalanced class. Using Smote, they created synthetic observations and 
equalized the class distribution. They applied the Recursive Feature Elimination (RFE) algorithm 
to reduce the number of features to identify the tumor. Later, they performed a logistic 
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regression model using 5-fold cross-validation to minimize the false positive rate and improved 
the accuracy compared to previous machine learning attempts. 
Jaideep et al. [17] aimed to classify prostate cancer using a protease activity nanosensor library 
and tried to identify aggressive disease on a different dataset. They implemented a bottom-up 
approach to design nanosensors to classify and detect prostate cancer. To identify proteolytic 
enzymes in human prostate cancer, they used Transcriptomic and proteomic analysis. They also 
tried measuring the activity by building a library of nanosensors. Moreover, they demonstrated 
that these nanosensors could classify aggressive tumors and outperformed a serum maker in 
mouse models. This library can be used at the screening test to identify patients with higher-risk 
tumors. 
Lemana et al. [18] developed an Artificial Neural Network (ANN) to classify normal and prostate 
cancer patients. They obtained the dataset from the research done by Zhou et al. [19]. They used 
Prostate-Specific Antigen (PSA) levels and Mitochondrial DNA copy number (mtDNA) samples. 
They aimed to classify samples with 175 normals and 177 tumors (according to biopsy results). 
The best performance is obtained with two-layer feedforward ANN with a log-sigmoid transfer 
function. The log-sigmoid (log-sig) transfer function is also used in a multilayer network, which 
uses the backpropagation algorithm. Moreover, they applied 10-fold cross-validation and 
resulted in sensitivity as 100%, specificity as 98.8%, and overall accuracy as 99.4%. They used a 
different dataset, which is obtained from the research done by Zhou et al. [19] and tried to 
separate healthy samples (normals) with diseased samples, but we are trying to distinguish 
samples with two diseases (Indolent and Aggressive). 
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2.2 Review of Machine Learning Methods 
In this section, we describe the usage of machine learning methods and their underlying 
principles. We also explained the reason in the introduction section, why we choose the machine 
learning methods. 
2.2.1 Support Vector Machine (SVM) 
A Support Vector Machine (SVM) [20] is a machine learning classifier, which is defined by 
a separating hyperplane. Support Vector Machine algorithm finds a hyperplane in an N-
dimensional space that classifies each data point (where N is the number of features).  
 
Figure 2.1: A two-class classification problem is shown in the above figure. The left side figure shows cases 
where data points may be separated from many different decision boundaries. The right side figure 





Figure 2.2: The Left-side graph represents hyperplane separating two classes in 2-dimension as a line, and 
right-side graphs show hyperplane separating two classes in 3-dimension. 
 
Hyperplanes help in classifying data points and depends upon the number of features. If the 
number of features in a dataset is 2, then the hyperplane is just a line. If the number of features 
in a dataset is 3, then the hyperplane is a plane. If the number of features is greater than 3, then 
it would be difficult to imagine a hyperplane. 
2.2.2 Logistic Regression (LogReg) 
Logistic Regression [21] is a technique for analyzing data that determines the dependent 
output (outcome) when there are one or more independent variables. In several cases, the 
outcome variable (dependent) is a dichotomous variable, in which there are only two possible 
outcomes. The goal is to find the best fitting model to describe the relationship between the 
dependent variable and the set of independent variables. Logistic sigmoid (log-sig) function is 
used to return a probability value by transforming the output, which can be mapped to discrete 
classes. Regularization techniques are used to avoid overfitting (any modification made to a 




Figure 2.3: The sigmoid function takes a real value and maps it to the range [0, 1]. The decision function is 
used to obtain the probability of class. 
 
2.2.3 Random Decision Forest (RDF) 
Random decision Forest [22] is a supervised machine learning algorithm which randomly 
creates and merges more than one decision tree into a forest. During training time, Random 
Decision Forest (RDF) algorithm operates by constructing a multitude of decision trees and 
outputting the class that is Classification or mean prediction (regression) of individual trees. It 
adds additional randomness to the model growing the trees. The best feature is searched among 
a random subset of features, instead of searching for the most crucial feature while splitting a 
node. Random decision forests correct habit of overfitting to their training data-set. The RDF 
operates by constructing a multitude of decision trees on various subsamples of the dataset and 
results in a mean prediction of decision trees to improve accuracy and avoid over-fitting. 
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2.2.4 Extra Tree Classifier (ETC) 
The Extra Tree [23] method is also known as extremely randomized trees. The main 
objective of an Extra Tree classifier is to randomize the input features of a tree, where the large 
proportion of the variance of the induced tree depends on the choice of optimal cut-point. It 
constructs randomized decision trees from the original learning samples and uses the above-
average decision to improve accuracy and avoid over-fitting. The method selects a cut point at 
random and drops the idea of using bootstrap copies of the training sample. Cut-point 
randomization often reduces the variance, when the bootstrapping idea is drooped and can also 
lead to an advantage in terms of bias. This method has yielded state-of-the-art results in high 
dimensional complex problems. 
2.2.5 Gradient Boosting Classifier (GBC) 
Gradient boosting classifier [24] is a machine learning technique used for classification 
and regression problems. It builds a model in a forward stage-wise fashion like other boosting 
methods. It allows for optimizing arbitrary differentiable loss functions. It involves three 
elements: (a) a loss function to be optimized, (b) a weak learner to make predictions, and (c) an 
additive model to add weak learners to minimize the loss function. The main objective of the 
Gradient boosting classifier is to minimize the loss of the model by adding weak learners in a 
stage-wise fashion using a similar procedure of Gradient descent. While adding a new weak 
learner, the existing weak learners in the model remain unchanged. In order to correct or 




2.2.6 K Nearest Neighbors (KNN) 
K nearest neighbor [25] is an algorithm that classifies new cases based on a similarity 
measure of all stored available instances. It has been used as a non-parametric technique in 
statistical estimation and pattern recognition. A case is being assigned to the common class 
among the K nearest neighbors, which is measured by a distance function and is also classified 
by a majority vote of its neighbors. If k=3, then the class is assigned to a class of its three nearest 
neighbors shown in Figure 2.4. 
 






2.2.7 eXtreme Gradient Boosting (XGB) 
The implementation of eXtreme Gradient Boosting [26] offers several advanced features 
for model tuning, algorithm enhancement, and computing environments. It can perform in three 
different forms of gradient boosting (Gradient Boosting (GB), Stochastic Gradient Boosting (GB), 
and Regularized Gradient Boosting (GB)). It is strong enough to support fine-tuning and addition 
of regularization parameters. It uses the regularized model formalization to avoid overfitting and 
results in better performance. Moreover, XGB trains faster. 
2.2.8 MultiClassClassifier 
MultiClassClassifier in WEKA is used for handling multi-class datasets with 2-class 
distribution classifiers. It is also capable of applying error-correcting output codes for increased 
accuracy. If the weights are not uniform, the base classifier cannot handle instance weights. So 
the data will be resampled with a replacement before being passed to the base classifier. It 
extends RandomizableSingleClassifierEnhancer and implements OptionHandler and 
weightedInstancesHandler. 
2.2.9 Logistic Model Trees (LMT) 
The logistic model tree (LMT) [27] is a classification model with a logistic regression 
function at the leaves. It is made up of an inner or non-terminal node along with a set of terminal 
nodes. It predicts a continuous numeric value for an instance that is defined over a fixed set of 
attributes. It constructs a piecewise linear approximation to the target function. LMT consists of 
a tree with a linear regression function at leaves. For instance, it is obtained by sorting it down 
to a leaf and also by using the prediction of the linear model associated with that leaf. It doesn’t 
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Chapter 3 – Experimental Materials and Methods 
3.1 Sources of Transcriptome and Clinical Data Sets 
 
We used publicly available gene expression and clinical data on indolent and aggressive 
PCa from the TCGA. The data were downloaded from the Genomic Data Commons [28], data 
portal using the data transfer tool. Because the same TCGA barcode structure was used for both 
clinical data and transcriptome data, we used the barcodes structure to integrate patient-based 
clinical data with sample-based genomics data. The total data set included N = 547 samples 
distributed as follows: N = 45 samples on indolent (GG=6), 246 samples with intermediate 
(GG=7), 204 of aggressive with lethal potential and 52 control samples. Gene expression data 
used in this thesis were derived from the same patient population. After annotating gene 
expression data with clinical information, we used the American Urological association 
classification protocol to verify and validate the classification of tumors according to GG because 
GG =7 follows a variable clinical course. We used the protocol to assign the tumors to either 
indolent or aggressive consistent with the guidelines. The tumor samples were either classified 
as 3 + 4 (primary + secondary), or 4 + 3 (primary and secondary) grade. The samples with GG: 3 + 
4 grades were assigned to a group of patients with Gleason Grade 6 (Indolent PCa). The samples 
with GG: 4 + 3 grades were assigned to a group of patients with Gleason Grade 8 to 10 (Aggressive 
PCa) [29]. 
 We performed data quality control and processing steps on gene expression data 
containing 60,483 probes across 547 samples. We implemented CPM (counts per million) filter 




Figure 3.1: Flowchart depicting project design and execution workflow in this project. Only the genes 
significantly differentially expressed between tumors and controls discovered in level 1 analysis were 
considered in the level 2 analysis. COAD: colon adenocarcinoma; DE: differential expression; TF: tumor-
free; TP: tumor presenting. 
 
filtering the data, we obtain a new dataset with 34,956 probes across 547 samples. We corrected 
the data for the library sizes for all the samples in with gene expression data. The resulting data 
set we normalized using CPM function to get log2 counts per million and checked for distribution 






3.2 Data Processing and Analysis for Gene Selection 
 
Using the limma and edgeR packages in R 3.8.0 [30], we processed the data and 
performed quality control by removing probes with low or zero expression values. The remaining 
data set was normalized using quantile normalization. Data normalization was performed using 
TMM. Composition biases are eliminated between libraries and generated a set of normalization 
factors (the product of the library sizes and factors defines the effective library size) using TMM 
normalization. TMM normalization scale relative to one sample and normalization factors 
multiple to unity across all libraries. Below Figure 3.4 shows the biased and unbiased MD plots 
side by side for the same sample (acb3e352-b255-4c41-b90f-5e5ed2273b06) before and after 
TMM normalization. Implemented in R before performing statistical tests. The processed 
normalized data contained 34,956 probes. 
3.2.1 Level-1 Analysis 
 
Using normalized data in R [30], we performed level 1 analysis comparing gene expression 
levels between tumor samples and controls for indolent and aggressive PCa separately. We used 
this baseline analysis to discover a signature of genes significantly (p < 0.05) associated with each 
disease state. We used the false discovery rate (FDR) procedure to correct for multiple hypothesis 
testing. The probes were ranked on p-values and –log fold change (-log FC). Differentially 
expressed significant probes between tumors and controls were considered to be associated with 
PCa. This initial level 1 analysis yielded 18,215 significantly (p < 0.05), and 21,042 significantly (p 
< 0.05) differentially expressed probes associated with Indolent and with aggression for model 1. 
For model 2, This initial level 1 analysis yielded 15,105 significantly (p < 0.05), and 20,712 
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significantly (p < 0.05) differentially expressed probes associated with Indolent and with 
aggressive. Additionally, an analysis comparing Gleason grade 7 yielded 15,105 significantly 
(p<0.05), and 20,712 significantly (p < 0.05) differentially expressed probes associated with 
Indolent and aggressive for model 1. 
The significant probes were then matched to the corresponding gene symbols and screened for 
duplicates. This analysis resulted in 3513 genes used in the downstream analysis in level 2 and 
classification. In addition to feature selection, multiple data visualization tools were also used to 
identify the most significant subset of probes for further analysis, including volcano plot, principal 
component analysis, and hierarchical clustering to heat-maps. Hierarchical clustering was 
performed only on the most highly significant genes to assess similarity in patterns of gene 
expression among the genes associated with the disease. For hierarchical clustering, we used the 
Pearson correlation as the measure of the distance between pairs of genes, and complete linkage 
as the clustering method. Hierarchical clustering was performed using Morpheus (Versatile 
matrix visualization and analysis software). 
We test for differentially expressed genes using our normalized data, and there are many 
packages to analyze RNA-Seq data. Limma package offers the voom function, which transforms 
the read counts into logCPMs while considering the mean-variance relationship in the data. We 
created a design matrix for the groups and made the column names of the design matrix a bit 
nicer. Here, the decision matrix tells us which samples correspond to each group. Now, we 
perform voom transformation using our decision matrix, and it will adjust the library sizes using 
the norm.factors already calculated and generate a plot of mean-variance trend (shown in Figure 
3.6 below). We can tell, if there are any genes that look really variable in our data and if we have 
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filtered low counts adequately using this plot. Below, Figure 3.3 shows the boxplot for the 
normalized data with expression log-transform values to compare to before normalization. 
Now we used limma to test for differential expression using voom transformed data. First of all, 
we fit a linear model for each gene in limma using the lmFit function. lmFit needs the design 
matrixand the Voom object that are already specified, which is stored within the voom object. 
Since we are interested in differences between groups, we need to specify which comparisons 
we want to test by specifying the comparison of interest using makeContrasts function. Here we 
get the statistics and estimated parameters of our comparison by using contrasts.fit function in 
limma. The final step is performing empirical Bayes shrinkage on the variance and estimates 
moderated t-statistics and the associated p-values by calling eBayes function and to generate a 
quick summary of DE genes for the contrast we used limma decideTests function. We used the 
volcano plot (shown in Figure 3.7 below) using the functions in limma for plotting the data with 
fit.cont as input. 
3.2.2 Level-2 Analysis 
 
We performed level 2 analysis on both the significant genes associated with the indolent 
and with the aggressive disease using gene expression data. We also compared gene expression 
levels between patients with Gleason grade 6 versus patients with Gleason grade 8-10.  
Moreover, we compared patients with Gleason grade 6 (3+4)  versus patients with Gleason score 
8-10 (4+3). Patients presenting with Gleason grade 3+4 versus patients presenting with Gleason 
grade 4 + 3 were also compared. Indolent and Aggressive patients (Ind Vs. Agg) to identify the 
features or genes to be used in classification algorithms. False discovery rate (FDR) procedure is 
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used to correct for multiple hypothesis testing. The genes were ranked on p-values and –log fold 
change (-log FC). Genes significantly differentially expressed between disease states were using 
the classification algorithms. 
3.2.3 Level-3 Analysis 
Application and evaluation of classification algorithms were involved using selected 
probes or features in this analysis using different cut-offs as determine by the p-values and logFC 
from the 2074 genes identified in the analysis. To test and validate the classification algorithms, 
few features were selected by performing feature selection at different threshold levels using 
the Genetic Algorithm. According to Machine Learning literature, five classifiers were selected 
with different fundamental approaches: Logistic Model Tree (LMT), MultiClassClassifier, SGD, 
SMO, SimpleLogistic. We also performed the stacking technique with few other classifiers with 
different fundamental principles: 
(a) Support vector machine (SVM). 
(b) Logistic Regression (LogReg). 
(c) Random Decision Forest (RDF). 
(d) Extra Tree Classifier (ETC). 
(e) Gradient Boosting Classifier (GBC). 
(f) K nearest neighbor (KNN). 
(g) eXtreme Gradient Boosting (XGBoost). 
To address the deficiency, we standardized the data and later processed it using a class-balancing 
algorithm due to the unstable design of the project. This algorithm is applied to each classifier as 
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well after the poor initial performance. Five subsets of 2074 significant genes were taken based 
on log-fold-change cutoffs of 0.5, 0.7, 1, 1.5, and 2. Here, we used 10-fold cross-validation 
technique on all mentioned subsets to prevent overfitting, with metrics averaged over all 10 folds 
and tested on each classifier. Weka 3.8.2 software [31] and the Genetic Algorithm are used to 
perform all classification and evaluation. 
In Figure 3.2, all the library sizes of samples in TCGA data are expressed using a barplot to see 
whether there are any major discrepancies between samples. It shows that the data quality is 
not good and is not normally distributed. To examine the distributions of raw counts, we need to 
log the counts. Here, we used box plots to check the distribution of the read counts on the log2 
scale. Figure 3.3 represents the boxplots of logCPM (log counts per million) before normalization. 
 
Figure 3.2: Library sizes of all samples expressed using a barplot constitutes the data quality and 




Figure 3.3: Figure checks the distribution of the read counts on the log2 scale of logCPM (log counts per 
million) before normalization. 
 
3.2.4 Normalization for Composite Bias 
We used TMM normalization to eliminate composition biases between libraries and 
generated a set of normalization factors (the product of the library sizes and factors defines the 
effective library size) [32]. TMM normalization scale relative to one sample and normalization 
factors multiple to unity across all libraries. Below Figure 3.4 shows the biased and unbiased MD 
plots side by side for the same sample (acb3e352-b255-4c41-b90f-5e5ed2273b06) before and 




Figure 3.4: Biases and unbiased MD plots side by side for the same sample. 
 
 
Figure 3.5: Figure represents the comparison of the data set before and after normalization of logCPM log 
counts per million. 
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3.2.5 Differential Expression with limma-voom 
We test for differentially expressed genes using our normalized data, and there are many 
packages to analyze RNA-Seq data. Limma package offers the voom function, which transforms 
the read counts into logCPMs while considering the mean-variance relationship in the data. We 
created a design matrix for the groups and made the column names of the design matrix a bit 
nicer. Here decision matrix tells us which samples correspond to each group. Now, we perform 
voom transformation using our decision matrix, and it will adjust the library sizes using the 
norm.factors already calculated and generate a plot of mean-variance trend (Figure 3.6). We can 
also say that if there are any genes in our normalized dataset that look really variable using this 
plot and if we have filtered low counts fairly. 
 
Figure 3.6: Figure showing the voom transformation using a decision matrix and mean-variance trend. 
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3.2.6 Testing for Differential Expression 
Now we used limma to test for differential expression using voom transformed data. First 
of all, we fit a linear model for each gene in limma using the lmFit function. lmFit needs the design 
matrix and the Vvoom object that are specified previously, which is stored within the voom 
object. Since we are interested in differences between groups, we need to specify which 
comparisons we want to test by specifying the comparison of interest using makeContrasts 
function. Here we get the statistics and estimated parameters of our comparison by using 
contrasts.fit function in limma. The final step is performing empirical Bayes shrinkage on the 
variance and estimates moderated t-statistics and the associated p-values by calling eBayes 
function and to generate a quick summary of DE genes for the contrast we used limma decide 
Tests function. We used the volcano plot (Figure 3.7) using the functions in limma for plotting the 
data with fit.cont as input. 
 
Figure 3.7: Figure showing that we used the threshold values to obtain the probes associated with 2 
different diseases (Indolent and Aggressive). 
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3.2.7 Multidimensional scaling plots (MDS) 
 
Multidimensional scaling plots (MDS) is a visualization of a principal components analysis, 
which determines the sources of variation in the given data. We used MDS-plots after analyzing 
our RNS-Seq data set. To make the plot more informative, we colored the samples (Aggressive: 
blue, Indolent: red) according to the grouping information and plotted them using points. Leading 
log fold change is used to calculate the distance between each pair of samples in the MDS plot, 
defined as the root-mean-square of the largest 500 log2-fold changes between that pair of 
samples. 
3.2.8 Hierarchical clustering with heatmaps 
Hierarchical clustering is an alternative for examining the relationships between samples. 
Heatmaps are a nice visualization to examine hierarchical clustering, and it is done using 
heatmap.2 function from the gplots package. It will calculate a matrix of Euclidean distances from 
the logCPM (logcounts objects) for the top 500 most variable genes from our normalized dataset. 




Figure 3.8: Figure representing a matrix of Euclidean distances from the logCPM (logcounts objects) for 
the 500 most variable genes. 
 
3.3 Application of Machine Learning 
We perform differential expression (D.E.) using both data sets (voom-normalized and 
clinical) and by comparing Indolent VS Normal and Aggressive Vs. Normal, we generate two probe 
sets with values of logFC, p-values, adjacent p-values, etc. 
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Now we filter the probes with adjacent p-values <0.05 in both the data sets (Indolent Vs. Normal, 
Aggressive Vs. Normal) and merged these two datasets by eliminating the common probes. We 
filter the latest normalized data with all the unique probes we obtained from the two datasets 
(Indolent Vs. Normal, Aggressive Vs. Normal). Applied Differential Expression (D.E) on this data 
and generated a Probe set (Indolent Vs. Aggressive) by comparing Indolent Vs. Aggressive. Later 
on, filtered the probe set with adjacent p-values <0.05 along with different log fold change values 
(0.5, 0.7, 1, 1.5, and 2). 
We further filtered the generated latest normalized data with the probes obtained from the 
probe set (Indolent Vs. Aggressive) and removed the normal samples. Now, we apply 10-fold 
cross-validation on the filtered normalized data and find the error rate. As the error rate is high, 
we can conclude that the data set containing samples with Gleason grade 7 are more 
misclassified. 
Now, we remove the samples which have Gleason grade 7 from the normalized dataset and 
perform differential expression (D.E) using both data sets (Normalized (without GG: 7) and 
clinical), and by comparing Indolent VS Normal and Aggressive Vs. Normal, we generate two 
probe sets with values of logFC, p-values, adjacent p-values, etc. 
We filter the probes with adjacent p-values <0.05 in both the data sets (Indolent Vs. Normal, 
Aggressive Vs. Normal) and merged these two datasets by deleting the common probes. We filter 
the latest normalized data (without GS: 7) with all the unique probes, we obtained from the two 
datasets (Indolent Vs. Normal, Aggressive Vs. Normal). Applied Differential Expression (D.E) on 
this data and generated a probe set (Indolent Vs. Aggressive) by comparing Indolent Vs. 
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Aggressive. Later on, we filtered the probe set with adjacent p-values <0.05 along with different 
log fold change values (0.5, 0.7, 1, 1.5, and 2). 
We again filtered the generated latest normalized data (without GG: 7) with the probes obtained 
from the probe set (Indolent Vs. Aggressive) and removed the normal samples. Now, we apply 
10-fold cross-validation on the filtered normalized data and find the error rate. As the error rate 
is low, we can say that almost all samples in the normalized data set (without GG: 7) are classified 
correctly. 
Here, we have classified above that the normalized data set with the samples (without GG: 7) 
correctly. So, we take the normalized dataset (without GG: 7) for training and the normalized 
data set with samples (only GG: 7) for testing. Now, we apply 10-fold cross-validation on these 
data sets and find out the samples which are misclassified. 
3.4 Correlation between ML and GG = validation 
3.4.1 Model-1: 
We applied a machine learning approach on all the probes with all the samples (495) with 
Gleason Grade (6, 7, 8, 9, 10) for all log-fold change values (0.5, 0.7, 1, 1.5, 2). We observed that 
the correctly classified instances in the normalized data set represented in Figure 5.1 is 
approximately 80%. The remaining 20% is mostly caused because of the misclassification in the 
samples (246) with Gleason Grade: 7 (3+4 and 4+3). We conclude that few samples with Gleason 
Grade: 6, 8, 9, and 10 are also misclassified. The below table represents the number of probes 
for each log-fold-change value. 
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Figure 5.4 in the result section shows that most of the samples with Gleason Grade: 7 are 
misclassified after applying the machine learning approach using different classifiers. 
3.4.2 Model-2: 
Here, we assume the samples (246) with Gleason Grade: 7 (3+4 and 4+3) are misclassified 
and removed these samples from the normalized data and apply machine learning on the 
remaining data set with samples (249) using the 5 classifiers mentioned above.  
Figure 5.12: in the result section shows that most of the samples (249) with Gleason Grade (6, 8, 
9, and 10) are classified with almost 90% correctly classified instances. We can also say that there 
are few incorrectly misclassified instances in these samples, too (Gleason Grade: 6, 8, 9, and 10). 
So, we used the samples (249) with Gleason Grade (6, 8, 9, and 10) to find the misclassified 
samples (246) with Gleason Grade: 7 by using machine learning.  
We applied machine learning on all the samples after classifying the misclassified instances with 




Chapter 4 – Performance Evaluation 
In the section, We plot a graph with misclassified instances in Figure 4.1. We performed 
machine learning approach on the normalized data-set using five different classifiers based on 
their principles and observed that the misclassified instances in samples with GG: 7 are more 
using MultiClassClassifier classifier and also found that the total number of misclassified 
instances in the whole data-set is more using Logistic Model Tree (LMT) followed by 
SimpleLogistic classifiers. The below-mentioned Table-1 and Table-2 contain the log-fold change 
values and the number of probes associated with the disease for both models (Model-1 and 
Model-2). We also created a performance evaluation matrics with their names and definitions 
mentioned in Table-3 below. 
 
Figure 4.1: Figure representing the misclassified instances in samples with both datasets (Samples with 








LMT MultiClassClassifier SGD SImpleLogistics SMO
Misclassified Instances
Misclassified Instances Only-7 Misclassified Instances All-Samples
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Figure 5.6 in the result section represents the normalized data set after classifying all the 
misclassified instances (495 samples) using a machine learning approach with different threshold 
values (0.5, 0.7, 1, 1.5, and 2) using Weka software tool. The below table is the final normalized 
data set contains 495 samples with a different set of probes for different threshold values. 
Table 1: Representation of the number of probes and log-fold change values for model-1. 
Model-1 







Table 2: Representation of the number of probes and log-fold change (LogFc) values for model-2. 
Model-2 








Table 3: Name and definition of performance evaluation metrics. 
Name of Metric Definition 
True Positive (TP) Correctly predicted sand boil images 
True Negative (TN) Correctly predicted sand boil images 
False Positive (FP) Incorrectly predicted sand boil images 
False Negative (FN) Incorrectly predicted sand boil images 
Recall/Sensitivity (Sens.) /True 





















FP + TP + TN + FN
 














F1 score (Harmonic mean of 
precision and recall) 
2TP
2TP + FP + FN
 
Mathews Correlation Coefficient 
(MCC) 
(TP  TN) − (FP  FN)




The idea of stacking based machine learning technique [33] has recently been successfully 
applied to solve bioinformatics and computer vision problems [34-39]. Stacking is a model, which 
obtains information from multiple different models and aggregates them to obtain a new model. 
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The generalized error rate will be minimized and yields to more accurate results when the 
information is gained from more than one predictive model. 
There are two stages of learners in stacking. The first stage of classifiers is known as base 
classifiers, and the second stage of classifiers are considered as meta classifiers. In stacking, more 
than one classifier is used in the first stage as base classifiers. The generalized error rate is 
reduced by combining the prediction probabilities from the base classifiers using a meta-
classifier. To supply the meta classifier with complementary clues, the classifiers in the first stage 
(base classifiers) must be different from one another based on their operating principles. 
To find the meta classifiers and base classifiers to use in the second and first stages of the stacking 
framework. we examined nine different machine learning algorithms: 
(h) Support vector machine (SVM). 
(i) Logistic Regression (LogReg). 
(j) Random Decision Forest (RDF). 
(k) Extra Tree Classifier (ETC). 
(l) Gradient Boosting Classifier (GBC). 
(m) K Nearest Neighbor (KNN). 
(n) eXtreme Gradient Boosting (XGBoost). 
We examined four different stacking models. The mentioned stacking models are built and 
optimized using Scikit-learn [40]. We used 2 sets of datasets (dataset with All-Samples and 
dataset with All-Samples except for Gleason grade: 7) in stacking. 
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The below-mentioned stacking models are performed using a dataset with All-Samples (Gleason 
grade: 6, 7, 8, 9, 10): 
i. LogReg, KNN, SVM as the base classifiers, SVM as the meta classifier. 
ii. LogReg, KNN, SVM as the base classifiers, XGBC as the meta classifier. 
iii. LogReg, KNN, SVM, XGBC as the base classifiers, XGBC as the meta classifier. 
iv. RDF, LogReg, KNN as the base classifiers, GBC as the meta classifier. 
v. RDF, LogReg, GBC as the base classifiers, KNN as the meta classifier. 
The below-mentioned stacking models are performed using a dataset with All-Samples except:7 
(Gleason grade: 6, 8, 9, 10): 
i. LogReg, KNN, SVM as the base classifier, SVM as the meta classifier. 
ii. LogReg, KNN, SVM as the base classifier, XGBC as the meta classifier. 
iii. LogReg, KNN, SVM, XGBC as the base classifier, XGBC as the meta classifier. 
iv. RDF, LogReg, KNN as the base classifier, GBC as the meta classifier. 
v. RDF, LogReg, GBC as base classifier, KNN as meta classifier.  
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Chapter 5 – Results and Discussions 
 
In this section, We used Principal component analysis to check the misclassified instances 
in our normalized data-set. The machine learning approach is also implemented for classifying 
the misclassified samples. We assume that the misclassification rate is high in samples with GG: 
7. Initially, the accuracy of our normalized dataset was around 75%, and Using weka, we classified 
most of the samples and improved accuracy to around 85%. Moreover, We implemented stacking 
techniques using different combinations of classifiers (a few of them as base classifiers and few 
as meta classifier) and improved the accuracy and reduced the error rate.  
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Figure 5.3: Principal component analysis on normalized data with all the samples except GG: 7 (Gleason 





Figure 5.6 represents the percentage of correctly classified instances for all the samples using 5 
different classifiers, and Figure 5.2 and Figure 5.3 contain the principal component analysis of 2 
data sets before classification. One is the principal component of all samples (495) with Gleason 
Grade: 6, 7, 8, 9, and 10 containing 2074 probes and the other is the principal component analysis 
of the samples (249) with Gleason Grade: 6, 8, 9, and 10 containing 3513 probes. As we can see, 
the samples ( Indolent and Aggressive) are mixing a little bit. We assumed this case as Model 1 
and applied machine learning approach. 
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Figure 5.5: Principal component analysis of samples with GG: 7  in 3-dimension. 
Figure 5.6 represents the percentage of correctly classified instances in the normalized data 
(Indolent Vs. Aggressive) with the samples containing 7, which consists of 3+4 (primary grade as 
3 and secondary grade as 4) or 4+3 (primary grade as 4 and secondary grade as 3) and Figure 5.5 







GG: Gleason grade 
Figure 5.6: Figure represents the accuracy of all the samples after classifying only samples with GG: 7 for 
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PCA diagram of All-Samples 
 
Figure 5.7: Principal component analysis of LMT classifier of all samples in 3-dimension with Gleason 
Grade: 6, 7, 8, 9, and 10. 
 
Figure 5.8: Principal component analysis of MultiClassClassifier classifier of all samples in 3-dimension 




Figure 5.9: Principal component analysis of SGD classifier of all samples in 3-dimension with Gleason 
Grade: 6, 7, 8, 9, and 10. 
 
Figure 5.10: Principal component analysis of SimpleLogistic classifier of all samples in 3-dimension with 




Figure 5.11: Principal component analysis of SMO classifier of all samples in 3-dimension with Gleason 
Grade: 6, 7, 8, 9, and 10. 
 
The above figures from Figure 5.7 to Figure 5.11 are the principal component analysis of all the 
samples (495) obtained by applying machine learning using 5 different classifiers after classifying 
the misclassified samples in the normalized data with the threshold (1.5). As the above Figure 5.6 
shows, the percentage of correctly classified instances is high for threshold (1.5). There are few 
samples still mix with others. The reason behind not finding all misclassified instances in GG: 7 is 







Figure 5.12: The figure represents the accuracy of all samples (with GG: 6, 8, 9, 10) for 5 different classifiers 
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First Part - Correctly Classified Instances (only 6 & 8-10 )
LMT MultiClassClassfier SGD SimpleLogistic SMO
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PCA of ALL-Samples except for GG: 7 
 
Figure 5.13: Principal component analysis of LMT classifier of samples with Gleason Grade: 6, 8, 9, and 10 
in 3-dimension. 
 
Figure 5.14: Principal component analysis of MultiClassClassifier classifier of samples with Gleason Grade: 








Figure 5.16: Principal component analysis of SimpleLogistic classifier of samples with Gleason Grade: 6, 




Figure 5.17: Principal component analysis of SMO classifier of samples with Gleason Grade: 6, 8, 9, and 10 
in 3-dimension. 
 
The above figures from Figure 5.13 to Figure 5.17 are the principal component analysis of the 
samples (249) with Gleason Grade: (6, 8, 9, 10) obtained by applying machine learning using 5 
different classifiers after classifying the misclassified samples in the normalized data with the 
threshold value: 1 and by eliminating the samples with Gleason Grade: 7. From the above Figure 
5.12, the percentage of correctly classified instances is high for threshold value: 1 in normalized 
data set.  
5.1 Stacking 
We tried different combinations of base classifiers and meta classifiers in the stacking 
technique. These classifiers were chosen based on different principles and their accuracies 
independently. The below tables shows the comparison of these stacking models. The 
performance of the stacking technique depends on the principles that each of base classifiers 
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helps the meta-learner to perform better. In our case, the model performs the best with better 
accuracy with data set containing all the samples with Gleason grade: 6, 7, 8, 9, and 10 and the 
model performs the best with the best accuracy with data set containing all the samples except 
Gleason grade: 7 (samples with Gleason grade: 6, 8, 9, and 10). Model and have almost a similar 
accuracy with all the samples with Gleason grade: 6, 7, 8, 9, and 10 and Model and have almost 
a similar accuracy with all the samples except Gleason grade: 7 (samples with Gleason Grade: 6, 
8, 9, 10). 
Table 4: Performance of various Classifiers with data set containing all the samples with Gleason 
grade: 6, 7, 8, 9, and 10. 

















































I. Suppert Vector 
Machine (SVM) 
0.91351 0.68800 0.85657 0.89655 0.90495 0.61332 0.80076 
II. Logistic Regression 
(LogReg) 
0.84865 0.67200 0.80404 0.88451 0.86621 0.50225 0.76032 
III. Random Decision 
Forest (RDF) 
0.92432 0.51200 0.82020 0.84864 0.88486 0.48733 0.71286 
IV. Extra Tree Classifier 
(ETC) 
0.92703 0.48800 0.81616 0.84275 0.88288 0.84275 0.71946 
V. Gradient Boosting 
Classifier (GBC) 
0.91081 0.54400 0.81818 0.85533 0.88220 0.49032 0.71941 
VI. K nearest neighbor 
(KNN) 
0.85676 0.59200 0.78990 0.86141 0.85908 0.44642 0.72438 
VII. eXtreme Gradient 
Boosting (XGBC) 





Table 5: Performance of various Stacking methods with data set containing all the samples with 
Gleason grade: 6, 7, 8, 9, and 10. 
















































I. LogReg, KNN, SVM as 
Base, SVM as Meta-
classifier 
0.99198 0.85124 0.95758 0.95373 0.97248 0.88337 0.92161 
II. LogReg, SVM, KNN, 
XGBC as Base, XGBC 
as Meta-classifier 
0.95989 0.83471 0.92929 0.94723 0.95352 0.80618 0.87295 
III. LogReg, KNN, SVM as 
Base, XGBC as Meta-
classifier 
0.972 0.8368 0.93131 0.949 0.961 0.8369 0.90690 
IV. RDF, LogReg, KNN as 
Base, GBC as Meta-
classifier 
0.98396 0.67769 0.90909 0.90418 0.94238 0.74373 0.83082 
V. RDF, LogReg, GBC as 
Base, KNN as Meta-
classifier 
0.93583 0.80992 0.90505 0.93834 0.93708 0.74368 0.87287 
 
Table 6: Performance of various Stacking methods with data set containing all the samples with 
Gleason grade: 6, 8, 9, and 10. 
















































I. LogReg, KNN, SVM as 
Base, SVM as Meta-
classifier 
0.98182 0.89655 0.97189 0.98630 0.98405 0.86558 0.93918 
II. LogReg, SVM, KNN, 
XGBC as Base, XGBC 
as Meta-classifier 
0.95127 0.7911 0.93812 0.96976 0.95991 0.71929 0.90869 
III. LogReg, KNN, SVM as 
Base, XGBC as Meta-
classifier 
0.95909 0.79310 0.94779 0.97235 0.96568 0.72100 0.91513 
IV. RDF, LogReg, KNN as 
Base, GBC as Meta-
classifier 
0.97727 0.62069 0.93574 0.95133 0.96413 0.66247 0.79898 
V. RDF, LogReg, GBC as 
Base, KNN as Meta-
classifier 
0.97727 0.58621 0.93173 0.94714 0.96197 0.63689 0.78174 
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Chapter 6 – Conclusions 
In this thesis, we compared different classifiers and determined the best one to use for 
classifying prostate cancer patients. We also implemented a stacking-based machine learning 
technique to increase the prediction accuracy of the machine learning model using a different 
combination of classifiers. Yes, the results were improved by using a stacking based machine 
learning technique. The accuracy was increased from ~85.657% to ~95.758%. 
 We also used the Genetic Algorithm method for feature elimination on both the data sets 
(samples with GG: 6, 7, 8, 9, 10, and samples with GG: 6, 8, 9, 10). The number of genes obtained 
for samples with GG: 6, 7, 8, 9, and 10 is 1020. The number of genes obtained for samples with 
GG: 6, 8, 9, and 10 is 1681. The best fitness values for all log-fold change values (0.5, 0.7, 1, 1.5, 
2) for both data sets were obtained using the Genetic Algorithm. The fitness value oftained for 
samples with GG: 6, 7, 8, 9, and 10 is 1.6140201. and the fitness value obtained for samples with 
GG: 6, 8, 9, and 10 is 1.74722.The highest accuracy obtained for our data set before applying 
machine learning is  about 75% for all classifiers. We also used the Weka software [41]  tool for 
classifying prostate cancer patients using different classifiers individually, and the highest 
accuracy obtained by Weka is about 85% for different classifiers individually.  
 Furthermore, we tried with few other classifiers separately and found that SVM performs 
the best 10-fold-cross-validation, achieving high accuracy of 86.465%, and XGBoost was also 
performing with high accuracy of 85.051%.  Moreover, stacking on all machine learning methods 
revealed an even better performance of 95.758% accuracy for data set containing GG: 6, 7, 8, 9, 
and 10, and 97.19% accuracy for the data set containing GG: 6, 8, 9, and 10. Hence, we found 
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that the samples with GG:7 are more misclassified compared to samples with GG: 6, 8, 9, and 10. 
The stacking machine learning technique might prove to be useful in classifying prostate cancer 
patients. In order to improve the accuracy or classify all the patients correctly, mutation-based 
or methylation-based analysis can be implemented to yield better results in the classification of 
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